Product Overview
Optimizing trial design for better outcomes
9 out of 10 drugs in development fail, costing billions annually, with late-stage failures being the most expensive due to prior investments. A key factor in these failures is sub-optimal trial design.
Certara’s Clinical Trial Simulator has been trusted for over a decade by leading pharmaceutical companies to optimize trial design and maximize the probability of success. By leveraging simulation and existing knowledge of the drug under study, Trial Simulator provides critical insights to improve study endpoints and reduce trial costs.
Deployment
- Web based
- Cloud Hosted
Pricing
- Subscription
- License Fee
More Information
- Streamline trial processes to improve efficiency and resource use
- Optimize dosing and treatment schedules
- Increase the probability of meeting study endpoints
Enhance trial design with a full suite of tools
Trial Simulator empowers researchers to design and optimize clinical trials with ease. It offers tools to create and compare study designs, access pre-built models, and conduct advanced analyses like ANOVA, bioequivalence, and Kaplan-Meier survival analysis. With features for population-based drug and disease modeling and support for various trial designs, including crossover and parallel studies, it streamlines trial planning and execution.
About the company
We transform drug development for the benefit of humans. Our commitment is to empower innovators, researchers, and regulatory experts with software and service solutions tailored exactly to meet their needs, fostering success across the entire drug development lifecycle.
Certara is dedicated to transforming drug discovery and development for good. We harness the power of biosimulation, advanced analytics, scientific, strategic and regulatory expertise to create a future where treatments reach patients faster and more efficiently.
